JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.28% |
| 2 | Technology | 15.04% |
| 3 | Healthcare | 12.52% |
| 4 | Financials | 10.55% |
| 5 | Consumer Discretionary | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4726
VanEck Uranium + Nuclear Energy ETF
NLR
$3.55B
| $251K | ﹤0.01% |
4,805
+1,942
| +68% | +$108K |
2021 Q1
5 quarters
|
|
4727
Evolus
EOLS
$508M
| $250K | ﹤0.01% |
21,523
-789
| -4% | -$9.31K |
2018 Q1
17 quarters
|
|
4728
CALL
Boyd Gaming
BYD
$4.8B
| $249K | ﹤0.01% |
+5,000
| New | +$289K |
2022 Q2
0 quarters
|
|
|
VTNR
4729
PUT
DELISTED
Vertex Energy, Inc
VTNR
| $249K | ﹤0.01% |
+23,700
| New | +$281K |
2022 Q2
0 quarters
|
|
|
BHACU
4730
DELISTED
Focus Impact BH3 Acquisition Company Units
BHACU
| $248K | ﹤0.01% |
25,000
-75,000
| -75% | -$744K |
2021 Q4
2 quarters
|
|
4731
Adicet Bio
ACET
$62.2M
| $247K | ﹤0.01% |
1,059
+11
| +1% | +$2.42K |
2021 Q2
4 quarters
|
|
4732
Aspen Aerogels
ASPN
$461M
| $247K | ﹤0.01% |
25,021
+7,547
| +43% | +$152K |
2020 Q2
8 quarters
|
|
4733
CALL
Polestar Automotive Holding UK
PSNY
$1.04B
| $247K | ﹤0.01% |
+933
| New | +$299K |
2022 Q2
0 quarters
|
|
4734
Pacer US Cash Cows 100 ETF
COWZ
$18.9B
| $246K | ﹤0.01% |
+5,721
| New | +$275K |
2022 Q2
0 quarters
|
|
4735
PUT
Nkarta
NKTX
$183M
| $246K | ﹤0.01% |
+20,000
| New | +$262K |
2022 Q2
0 quarters
|
|
4736
RBB Bancorp
RBB
$440M
| $246K | ﹤0.01% |
11,904
-73,145
| -86% | -$1.58M |
2017 Q4
18 quarters
|
|
4737
Hippo Holdings
HIPO
$832M
| $245K | ﹤0.01% |
11,153
+6,915
| +163% | +$255K |
2021 Q4
2 quarters
|
|
4738
PUT
Owens Corning
OC
$9.26B
| $245K | ﹤0.01% |
+3,300
| New | +$291K |
2022 Q2
0 quarters
|
|
4739
Oportun Financial
OPRT
$378M
| $245K | ﹤0.01% |
29,548
-21,501
| -42% | -$248K |
2019 Q3
11 quarters
|
|
4740
ThredUp
TDUP
$280M
| $244K | ﹤0.01% |
97,719
-384,900
| -80% | -$2.08M |
2021 Q1
5 quarters
|
|
4741
Millicom
TIGO
$14.4B
| $244K | ﹤0.01% |
16,965
-10,066
| -37% | -$207K |
2020 Q1
9 quarters
|
|
|
TFFP
4742
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
| $244K | ﹤0.01% |
1,725
-103
| -6% | -$14.4K |
2020 Q2
8 quarters
|
|
4743
Stoneridge
SRI
$191M
| $243K | ﹤0.01% |
14,201
+1,822
| +15% | +$34.6K |
2013 Q2
36 quarters
|
|
|
DSKE
4744
DELISTED
Daseke, Inc. Common Stock
DSKE
| $243K | ﹤0.01% |
37,939
-68,471
| -64% | -$523K |
2017 Q3
19 quarters
|
|
|
WARR
4745
DELISTED
Warrior Technologies Acquisition Company
WARR
| $243K | ﹤0.01% |
24,480
-390,779
| -94% | -$3.87M |
2021 Q2
4 quarters
|
|
4746
Blend Labs
BLND
$248M
| $242K | ﹤0.01% |
102,624
-1,672,355
| -94% | -$6.25M |
2021 Q3
3 quarters
|
|
4747
Dyne Therapeutics
DYN
$2.95B
| $242K | ﹤0.01% |
35,320
+7,462
| +27% | +$51.4K |
2020 Q4
6 quarters
|
|
|
HOLI
4748
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $242K | ﹤0.01% |
16,325
-23,806
| -59% | -$365K |
2021 Q3
3 quarters
|
|
|
BRCN
4749
DELISTED
Burcon NutraScience Corporation
BRCN
| $242K | ﹤0.01% |
58,524
| – | – |
2021 Q2
4 quarters
|
|
4750
Atlanticus Holdings
ATLC
$1.35B
| $241K | ﹤0.01% |
6,856
+487
| +8% | +$19.5K |
2020 Q2
8 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,728 reduced and 609 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 609 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.